HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy (Q27851461)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy
scientific article

    Statements

    HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy (English)
    Samanthi A Perera
    Takeshi Shimamura
    Maria G Raso
    Christa L Borgman
    Sara Zaghlul
    Kathleyn A Brandstetter
    Shigeto Kubo
    Masaya Takahashi
    Lucian R Chirieac
    Robert F Padera
    Geoffrey I Shapiro
    Ulrich Guertler
    Pilar Garin Chesa
    Flavio Solca

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit